WNT5A is a putative epi-driver of prostate cancer metastasis to the bone.

Emma J WilkinsonKelsie RaspinRoslyn C MalleyShaun DonovanLouise M NottAdele F HollowayJoanne L Dickinson

Published in: Cancer medicine (2024)

Given the limited effective therapies available for metastatic cancer sufferers, particularly those whose disease has metastasised to the bone, WNT5A presents as a potential putative target for therapy.

Keyphrases

prostate cancer
bone mineral density
cell proliferation
stem cells
papillary thyroid
soft tissue
squamous cell carcinoma
bone loss
small cell lung cancer
radical prostatectomy
bone regeneration
squamous cell
postmenopausal women
body composition
risk assessment
young adults
childhood cancer
replacement therapy